Thus, these results not only shed light on understanding the mechanisms of aberrant high HGF expression in NSCLC epithelial cells, but have also led to the discovery of a biomarker that can be used to identify NSCLC patients with a higher risk of metastasis. Here, HGF is linked to non-small cell lung carcinoma.